Clinical measure | Target |
---|---|
HbA1c | < 6.5% |
Total cholesterol | <4.0 mmol/L |
LDL cholesterol | <2.0 mmol/L |
BP if microalbuminuria absent | < 130/80 |
BP if microalbuminuria present | < 125/75 |
Renal protection | All patients with microalbuminuria to be on angiotensin converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) unless contraindicated |
Anti-thrombotic | All patients to be on anti-platelet agent unless contraindicated |